NASDAQ:MCRB | Operating Income | Seres Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$21.27M
2026-03-31-$20.91M
2025-12-31-$19.38M
2025-09-30-$22.48M
2025-06-30-$24.88M
2025-03-31-$27.24M
2024-12-31-$28.84M
2024-09-30-$29.17M
2024-06-30-$28.87M
2024-03-31-$34.44M
2023-12-31-$37.02M
2023-09-30-$44.59M
2023-06-30$49.52M
2023-03-31-$70.57M
2022-12-31-$1.73M
2022-09-30-$59.11M
2022-06-30-$63.33M
2022-03-31-$55.75M
2021-12-31-$49.43M
2021-09-30$68.41M
2021-06-30-$48.14M
2021-03-31-$35.33M
2020-12-31-$17.9M
2020-09-30-$30M
2020-06-30-$20.55M
2020-03-31-$19.69M
2019-12-31-$19.19M
2019-09-30-$17.18M
2019-06-30-$10.95M
2019-03-31-$24.55M
2018-12-31-$21.67M
2018-09-30-$22.21M
2018-06-30-$28.14M
2018-03-31-$28.27M
2017-12-31-$29.78M
2017-09-30-$7.31M
2017-06-30-$28.42M
2017-03-31-$25.89M
2016-12-31-$25.67M
2016-09-30-$19.1M
2016-06-30-$28.14M
2016-03-31-$19.92M
2015-12-31-$19.79M
2015-09-30-$14.56M
2015-06-30-$12.34M
2015-03-31-$12.34M
2014-12-31-$7.21M
2014-09-30-$3.58M
2014-06-30-$2.62M

Annual Operating Income

DateOperating Income
2025-12-31-$93.97M
2024-12-31-$121.32M
2023-12-31-$195.1M
2022-12-31-$179.91M
2021-12-31-$64.49M
2020-12-31-$88.13M
2019-12-31-$71.88M
2018-12-31-$100.28M
2017-12-31-$91.4M
2016-12-31-$92.84M
2015-12-31-$54.86M
2014-12-31-$15.08M
2013-12-31-$6.05M